Sponsored Links 
C.R. Bard (BCR)
Print
ShareC.R. Bard (BCR - Analyst Report) operates in vascular, urology, oncology and surgical specialty markets. These end-markets should remain insulated from the current economic turmoil.
Many of the company's products are used in interventional medicine -- life-saving surgical procedures. Future quarters will be met with a headwind from foreign exchange.
However, with less than a third of sales outside of the United States, the impact will be less than that for BCR's competitors. We retain our Outperform rating on the shares.
C.R. Bard (BCR) : FULL ANALYST REPORT
|
Read the full analyst report on BCR
Loading Stories...
0.00